Company Search:
Advanced Search
Sponsored Links
CASI Pharmaceuticals Inc Company Snapshot
CASI Pharmaceuticals Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares CASI Pharmaceuticals Inc with three other pharmaceutical manufacturers in North America: RegeneRx Biopharmaceuticals, Inc. (2015 sales of $60,612.00 ), Acadia Pharmaceuticals, Inc. ($61,000.00 of which 100% was Molecular Drugs), and Vitality Products Inc which is based in Canada (63,916.00 Canadian Dollars [US$48,275.12 ] ).

Sales Analysis.
  Stock Performance Chart for CASI Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 3.43
(Figures in U.S. Dollars)
1 Week -3.4%   13 Weeks -2.3%  
4 Weeks -56.5%   52 Weeks 42.9%  
CASI Pharmaceuticals Inc Key Data:
  Ticker: CASI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 47,712
(Year Ending Jan 2016).
Employees: 22
  Currency: U.S. Dollars Market Cap: 320,365,252
  Fiscal Yr Ends: December Shares Outstanding: 93,400,948
  Share Type: Common Closely Held Shares: 43,891,935
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.